anti- alpha-synuclein antibody

Delve into the world of neurodegenerative diseases and protein aggregation with our specialized Anti-Alpha-Synuclein Monoclonal Antibody, available in a 100µg size. Alpha-synuclein is a key protein implicated in the pathogenesis of Parkinson's disease and other synucleinopathies. This meticulously crafted monoclonal antibody offers exceptional specificity and sensitivity, making it an ideal choice for various research applications, from immunohistochemistry to protein-protein interaction studies.

Our Anti-Alpha-Synuclein Monoclonal Antibody is characterized by its outstanding performance. It has undergone rigorous validation and testing, ensuring consistent and reproducible results while minimizing experimental variability. With 100µg of antibody, this product provides ample material for multiple experiments, striking a balance between cost-effectiveness and practicality.

Designed for ease of use, this antibody is suitable for researchers of all experience levels, enhancing the precision and reliability of experiments across various laboratory techniques. Contribute to a deeper understanding of neurodegenerative processes and protein misfolding with confidence, supported by our high-quality Anti-Alpha-Synuclein Monoclonal Antibody. Drive advancements in neuroscience research and be part of groundbreaking discoveries in neurodegeneration.

Product Name

alpha-synuclein antibody

Size

100µg

Form

liquid

Purification

protein A+G purified

Purity

≥95% as determined by SDS-PAGE

Host

Mouse

Clonality

monoclonal

Isotype

IgG1

Storage

PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)

BACKGROUND

Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene.

IMMUNOGEN INFORMATION

Immunogen

synuclein, alpha (non A4 component of amyloid precursor)

Synonyms

Alpha synuclein, NACP, PARK1, PARK4, SNCA

Observed MW

18 kDa

APPLICATION

Tested Application

ELISA, IHC, WB

Recommended Dilution

WB: 1:500 - 1:2000; IHC: 1:500 - 1:2000

UNIPROT INFORMATION

UniProt ID

P37840

IMAGES